The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
Abstract
BACKGROUND: We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular conduction delays. METHODS: A total of 1520 patients who had advanced heart failure (New York Heart Association class III or IV) due to ischemic or nonischemic cardiomyopathies and a QRS interval of at least 120 msec were randomly assigned in a 1:2:2 ratio to receive optimal pharmacologic therapy (diuretics, angiotensin-converting-enzyme inhibitors, beta-blockers, and spironolactone) alone or in combination with cardiac-resynchronization therapy with either a pacemaker or a pacemaker-defibrillator. The primary composite end point was the time to death from or hospitalization for any cause. RESULTS: As compared with optimal pharmacologic therapy alone, cardiac-resynchronization therapy with a pacemaker decreased the risk of the primary end point (hazard ratio, 0.81; P=0.014), as did cardiac-resynchronization therapy with a pacemaker-defibrillator (hazard ratio, 0.80; P=0.01). The risk of the combined end point of death from or hospitalization for heart failure was reduced by 34 percent in the pacemaker group (P<0.002) and by 40 percent in the pacemaker-defibrillator group (P<0.001 for the comparison with the pharmacologic-therapy group). A pacemaker reduced the risk of the secondary end point of death from any cause by 24 percent (P=0.059), and a pacemaker-defibrillator reduced the risk by 36 percent (P=0.003). CONCLUSIONS: In patients with advanced heart failure and a prolonged QRS interval, cardiac-resynchronization therapy decreases the combined risk of death from any cause or first hospitalization and, when combined with an implantable defibrillator, significantly reduces mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While clinical improvements are generally achieved, six-month nonresponder rates have been reported to be as high as 32–43%11,13, which is partially attributed to anatomic constraints of lead positioning14.”
From Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers (2020) · cites this paper as [13]
In the citing paper
“Device therapies (implantable cardioverter defibrillator [ICD], cardiac resynchronization therapy [CRT], and CRT with an implantable defibrillator [CRT-D]) have similar efficacies and risks in patients with HFrEF with or without diabetes.[522][523][524][525]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [524]
Citations
Cites
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Cardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648
CARDIAC RESYNCHRONIZATION IN CHRONIC HEART FAILURE
Braham, W. I. T. A., Isher, W. E. G. F., Mith, L. S., Elurgio, D. A. B. D., Eon, A. N. R. L., Oh, E., Ocovic, D. U. Z. K., Acker, M. G., Lavell, L. C., Ayes, D. A. L. H., et al. (2002) · Cited by 3,808
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Self-citationDiscrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Self-citationSt John Sutton, M. G., Plappert, T., Abraham, W. T., Smith, A. L., DeLurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Fisher, W. G., Ellestad, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065226.24159.e9 · Cited by 1,124
Auricchio, A., Stellbrink, C., Sack, S., Block, M., Vogt, J. Ü., Bakker, P., Huth, C., Schöndube, F., Wolfhard, U., Böcker, D., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01895-8 · Cited by 1,026
Linde, C., Leclercq, C., Rex, S., Garrigue, S., Lavergne, T., Cazeau, S., McKenna, W., Fitzgerald, M., Deharo, J.-C., Alonso, C., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01932-0 · Cited by 973
Baldasseroni, S., Opasich, C., Gorini, M., Lucci, D., Marchionni, N., Marini, M., Campana, C., Perini, G., Deorsola, A., Masotti, G., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121264 · Cited by 800
Cited by
Items 501–600 of 1,014
Left bundle‐branch block—pathophysiology, prognosis, and clinical management
Francia, P., Balla, C., Paneni, F., & Volpe, M. (2007) · Clinical Cardiology · doi:10.1002/clc.20034 · Cited by 118
Forleo, G. B., Rocca, D. G. D., Papavasileiou, L. P., Molfetta, A. D., Santini, L., & Romeo, F. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.09.076 · Cited by 97
Auricchio, A., Metra, M., Gasparini, M., Lamp, B., Klersy, C., Curnis, A., Fantoni, C., Gronda, E., & Vogt, J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.07.087 · Cited by 97
Conventional Versus Biventricular Pacing in Heart Failure and Bradyarrhythmia: The COMBAT Study
Filho, M. M., de Siqueira, S. F., Costa, R., Greco, O. T., Moreira, L. F. P., d’Ávila, A., & Heist, E. K. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.12.008 · Cited by 109
Mascioli, G., Padeletti, L., Sassone, B., Zecchin, M., Lucca, E., Sacchi, S., Boggian, G., TONDO, A. L., Belvito, C., Bakhtadze, N., et al. (2012) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2012.03427.x · Cited by 96
Kramer, D. B., Friedman, P. A., Kallinen, L. M., Morrison, T. B., Crusan, D. J., Hodge, D. O., Reynolds, M. R., & Hauser, R. G. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.08.031 · Cited by 95
Tee, M., Noble, J. A., & Bluemke, D. A. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.182 · Cited by 96
Sudden cardiac death and chronic kidney disease: From pathophysiology to treatment strategies
Lullo, L. D., Rivera, R. F., Bàrbera, V., Bellasi, A., Cozzolino, M. G., Russo, D., Pascalis, A. D., Banerjee, D., Floccari, F., & Ronco, C. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.170 · Cited by 106
Outcomes With Left Bundle Branch Block and Mildly to Moderately Reduced Left Ventricular Function
Witt, C. M., Wu, G., Yang, D., Hodge, D. O., Roger, V. L., & Cha, Y. (2016) · JACC Heart Failure · doi:10.1016/j.jchf.2016.07.002 · Cited by 100
Bennett, M. T., Parkash, R., Nery, P. B., Sénéchal, M., Mondesert, B. A., BIRNIE, D. H., Sterns, L. D., Rinne, C., Exner, D. V., Philippon, F., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.09.009 · Cited by 109
Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease
Dukkipati, S. R., Koruth, J. S., Choudry, S., Miller, M. A., Whang, W., & Reddy, V. Y. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.030 · Cited by 109
Clémenty, N., Carion, P. L., LÉOTOING, L. D., Lamarsalle, L., Wilquin-Bequet, F., Brown, B., Verhees, K. J. P., Fernandes, J., & Deharo, J. (2018) · EP Europace · doi:10.1093/europace/eux387 · Cited by 96
Mechanical Device–Based Methods of Managing and Treating Heart Failure
MANCINI, D. M., & Burkhoff, D. (2005) · Circulation · doi:10.1161/circulationaha.104.481259 · Cited by 100
Vijgen, J. M., Botto, G., Camm, A. J., Höijer, C. J., Jung, W., Heuzey, J. L., Lubiński, A., Norekvål, T. M., Santomauro, M., Schalij, M. J., et al. (2009) · EP Europace · doi:10.1093/europace/eup112 · Cited by 96
Leitlinien zur Implantation von Defibrillatoren
Hohnloser, S. H., Andresen, D., Block, M. S., Breithardt, G., Jung, W., Klein, H. H., Kuck, K. H., Lüderitz, B., & Steinbeck, G. (2001) · Steinkopff eBooks · doi:10.1007/978-3-642-57631-7_8 · Cited by 94
Ypenburg, C., Sieders, A., Bleeker, G. B., Holman, E. R., van der Wall, E. E., Schalij, M. J., & Bax, J. J. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.035 · Cited by 96
“Previous studies have demonstrated that cardiac resynchronization therapy (CRT) not only improves clinical status (New York Heart Association (NYHA) class, quality of life and exercise capacity) (1-3), but also reverses left ventricular (LV) remodeling and improves systolic function (4,5).”
BackgroundVidal, B., Sitges, M., Marigliano, A., Delgado, V., Dı́az-Infante, E., Azqueta, M., Tamborero, D., Tolosana, J. M., Berruezo, A., Pérez‐Villa, F., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.04.046 · Cited by 94
Leitlinien zur Implantation von Defibrillatoren
Jung, W., Andresen, D., Block, M. S., Böcker, D., Hohnloser, S. H., Kück, K., & Sperzel, J. (2006) · Clinical Research in Cardiology · doi:10.1007/s00392-006-0475-7 · Cited by 126
“Die Mortalität alleine (sekundärer Endpunkt) wurde durch den CRT nichtsignifikant um 24% (absolut: 4,6%) gesenkt (p = 0,06), durch den CRT-D dagegen signifikant um 36% (absolut: 6,8%) (p = 0,004) [9].”
BackgroundInfluentialImplantable Cardiac Device Procedures in Older Patients: Use and In-Hospital Outcomes
Swindle, J. P., Rich, M. W., McCann, P., Burroughs, T. E., & Hauptman, P. J. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.30 · Cited by 103
Risk stratification in surgically repaired tetralogy of Fallot
Khairy, P., Dore, A., Poirier, N. C., Marcotte, F., Ibrahim, R., Mongeon, F., & Mercier, L. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.38 · Cited by 96
Kedia, N., Ng, K., Apperson-Hansen, C., Wang, C., TCHOU, P. J., Wilkoff, B. L., & Grimm, R. A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.04.017 · Cited by 95
Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure
Piccini, J. P., Hernandez, A. F., Dai, D. W. H., Thomas, K. L., Lewis, W. R., Yancy, C. W., Peterson, E. D., & Fonarow, G. C. (2008) · Circulation · doi:10.1161/circulationaha.108.773838 · Cited by 98
Risum, N., Strauss, D. G., Søgaard, P., Loring, Z., Hansen, T. F., Bruun, N. E., Wagner, G. S., & KISSLO, J. A. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.04.005 · Cited by 96
Nishisato, K., Hashimoto, A., Nakata, T., Doi, T., Yamamoto, H., Nagahara, D., Shimoshige, S., Yuda, S., Tsuchihashi, K., & Shimamoto, K. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.074971 · Cited by 94
Lip, G. Y. H., Heinzel, F. R., Gaïta, F., González‐Juanatey, J. R., Heuzey, J. Y. L., Potpara, T., Svendsen, J. H., Vos, M. A., Anker, S. D., Coats, A. J. S., et al. (2015) · EP Europace · doi:10.1093/europace/euv191 · Cited by 111
Vijayaraman, P., Pokharel, P., Subzposh, F. A., Oren, J. W., Storm, R. H., Batul, S. A., Beer, D. A., Hughes, G., Leri, G., Manganiello, M., et al. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2023.08.003 · Cited by 103
Strategies to improve cardiac resynchronization therapy
Vernooy, K., van Deursen, C. J. M., Strik, M., & Prinzen, F. W. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.67 · Cited by 95
Ferreira, A. M., Adragão, P., Cavaco, D., Candeias, R., Morgado, F. B., Santos, K. R., Santos, E., & Silva, J. A. (2008) · EP Europace · doi:10.1093/europace/eun135 · Cited by 91
Kuschyk, J., Roeger, S., Schneider, R., Streitner, F., Stach, K., Rudic, B., Weiß, C., Schimpf, R., Papavasilliu, T., Rousso, B., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.12.178 · Cited by 93
Matsumoto, Y., Krishnan, S., Fowler, S. J., Saremi, F., Kondo, T., Ahsan, C. H., Narula, J., & Gurudevan, S. V. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.01.072 · Cited by 94
Docherty, K. F., Jhund, P. S., Anand, I., Bengtsson, O., Böhm, M., de Boer, R. A., DeMets, D. L., Desai, A. S., Drozdz, J., Howlett, J., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047480 · Cited by 95
Self-citationSex-Specific Mortality Risk by QRS Morphology and Duration in Patients Receiving CRT
Zusterzeel, R., Curtis, J. P., Caños, D., Sanders, W. E., Selzman, K. A., Piña, I. L., Spatz, E. S., Bao, H., Ponirakis, A., Varosy, P. D., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1162 · Cited by 93
Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes
Merchant, F. M., Heist, E. K., McCarty, D., Kumar, P., Das, S., Blendea, D. C., Ellinor, P. T., Mela, T., Picard, M. H., Ruskin, J. N., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.01.035 · Cited by 95
Altman, R., Parks, K. A., Schlett, C. L., Orencole, M. P., Park, M.-Y., Truong, Q. A., Deeprasertkul, P., Moore, S. A., Barrett, C. D., Lewis, G. D., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs107 · Cited by 92
2013 ESC GUIDELINES ON CARDIAC PACING AND CARDIAC RESYNCHRONIZATION THERAPY
Brignole, M., Auricchio, A., Barón‐Esquivias, G., Bordachar, P., Boriani, G., Breithardt, O. A., Cleland, J. G. F., Deharo, J., Delgado, V., Elliot, P. M., et al. (2014) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2014-4-5-63 · Cited by 95
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT
Poole, J. E., Olshansky, B., Mark, D. B., Anderson, J., Johnson, G. W., Hellkamp, A. S., Davidson-Ray, L. D., Fishbein, D. P., Boineau, R., Anstrom, K. J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.061 · Cited by 91
Trimble, M. A., Borges‐Neto, S., Smalheiser, S. A., Chen, J., Honeycutt, E. F., Shaw, L. K., Heo, J., Pagnanelli, R., Tauxe, E. L., Garcia, E. V., et al. (2007) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2007.01.041 · Cited by 94
Drugs for Left Ventricular Remodeling in Heart Failure
Frigerio, M., & Roubina, E. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.09.060 · Cited by 100
Cardiac resynchronization therapy in congenital heart disease
Khairy, P., Fournier, A., Thibault, B., Dubuc, M., Thérien, J., & VOBECKY, S. J. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.06.065 · Cited by 93
“CRT may improve quality of life, New York Heart Association (NYHA) functional class, exercise capacity, and left ventricular systolic function [1–6].”
BackgroundZanon, F., Baracca, E., Pastore, G., Fraccaro, C., Roncon, L., Aggio, S., Noventa, F., Mazza, A., & Prinzen, F. W. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000850 · Cited by 92
Ommen, S., Mital, S., Burke, M. A., Day, S., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J., Kantor, P., et al. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.001 · Cited by 62
Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011): Digest Version
JCS Joint Working Group (2012) · Circulation Journal · doi:10.1253/circj.cj-66-0053 · Cited by 103
Cannesson, M. P., Tanabe, M., Suffoletto, M. S., McNamara, D. M., Madan, S., Lacomis, J. M., & Gorcsan, J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.045 · Cited by 93
Varma, N., Manne, M. B., Nguyen, D., He, J., Niebauer, M. J., & TCHOU, P. J. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.04.001 · Cited by 92
Cunnington, C., Kwok, C. S., Satchithananda, D. K., Patwala, A., Khan, M. A., Zaidi, A. M., Ahmed, F. Z., & Mamas, M. A. (2015) · Heart · doi:10.1136/heartjnl-2014-306811 · Cited by 96
Tian, Y., Zhang, P., Li, X., Gao, Y., Zhu, T., Wang, L., Li, D., Wang, J., Yuan, C., & Guo, J. (2013) · EP Europace · doi:10.1093/europace/eut049 · Cited by 102
Vijayaraman, P., Herweg, B., Verma, A., Sharma, P. S., Batul, S. A., Ponnusamy, S. S., Schaller, R. D., Cano, Ó., Molina‐Lerma, M., Čurila, K., et al. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.04.024 · Cited by 94
Selecting Patients for Cardiac Resynchronization Therapy
Hawkins, N. M., Petrie, M. C., Burgess, M. I., & McMurray, J. J. V. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.062 · Cited by 92
Patwala, A., Woods, P. R., Sharp, L. K., Goldspink, D. F., Tan, L. B., & Wright, D. J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.063 · Cited by 92
Lin, X., Xu, H., Zhao, X., Folks, R. D., Garcia, E. V., Soman, P., & Chen, J. (2010) · Journal of Nuclear Cardiology · doi:10.1007/s12350-010-9238-y · Cited by 91
Stavrakis, S., Garabelli, P. J., & Reynolds, D. W. (2012) · EP Europace · doi:10.1093/europace/eus193 · Cited by 95
Beggs, S. A. S., Jhund, P. S., Jackson, C. E., McMurray, J. J. V., & Gardner, R. S. (2017) · Heart · doi:10.1136/heartjnl-2016-310850 · Cited by 96
Yarnoz, M. J., & Curtis, A. B. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.12.027 · Cited by 91
Anderson, L. J., Miyazaki, C., Sutherland, G. R., & Oh, J. K. (2008) · Circulation · doi:10.1161/circulationaha.107.721332 · Cited by 89
Sardu, C., Santamaria, M., Rizzo, M. R., Barbieri, M., Marino, M., Paolisso, G., Santulli, G., & Marfella, R. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12823 · Cited by 95
Dong, K., Shen, W.-K., Powell, B. D., Dong, Y.-X., Rea, R. F., Friedman, P. A., Hodge, D. O., Wiste, H. J., Webster, T. L., Hayes, D. L., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.02.011 · Cited by 95
Right Ventricular Dysfunction and Adverse Outcome in Patients With Advanced Heart Failure
Field, M. E., Solomon, S. D., Lewis, E. F., Kramer, D. B., Baughman, K. L., Stevenson, L. W., & Tedrow, U. B. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.06.472 · Cited by 89
A unique method by which to quantitate synchrony with equilibrium radionuclide angiography
O’Connell, J. W., Schreck, C., Moles, M., Badwar, N., DeMarco, T., Olgin, J. E., Lee, B. K., Tseng, Z. H., Kumar, U., & Botvinick, E. H. (2005) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2005.05.006 · Cited by 87
Self-citationCleland, J. G. F., Freemantle, N., Daubert, J., Toff, W. D., Leisch, F., & Tavazzi, L. (2007) · Heart · doi:10.1136/hrt.2007.128991 · Cited by 91
Postero‐Lateral Scar Tissue Resulting in Non‐Response to Cardiac Resynchronization Therapy
Bleeker, G. B., Schalij, M. J., van der Wall, E. E., & Bax, J. J. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00499.x · Cited by 87
Advances in Echocardiographic Imaging in Heart Failure With Reduced and Preserved Ejection Fraction
Omar, A. M. S., Bansal, M., & Sengupta, P. P. (2016) · Circulation Research · doi:10.1161/circresaha.116.309128 · Cited by 103
2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology (2020) · Russian Journal of Cardiology · doi:10.15829/29/1560-4071-2020-4083 · Cited by 88
Merkely, B. P., Hatala, R., Wranicz, J. K., Duray, G. Z., Földesi, C., Som, Z., Németh, M., Gościńska-Bis, K., Gellér, L., Zima, E., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad591 · Cited by 107
“1,2 9 Since RV pacing–induced dyssynchrony is comparable to intrinsic LBBB, patients with significant RV pacing burden and LV dysfunction appear to be at increased risk of further LV remodelling and adverse outcomes.”
BackgroundModulation of cardiac tissue electrophysiological properties with light-sensitive proteins
Nussinovitch, U., Shinnawi, R., & Gepstein, L. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu037 · Cited by 91
Heywood, J. T., Fonarow, G. C., Yancy, C. W., Albert, N. M., Curtis, A. B., Gheorghiade, M., Inge, P. J., McBride, M. L., Mehra, M. R., O’Connor, C. M., et al. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.912683 · Cited by 88
Barth, A. S., Aiba, T., Kuhns, V. L. H., DiSilvestre, D. A., Chakir, K., Colantuoni, C., Tunin, R. S., Dimaano, V. L., Yu, W., Abraham, T. P., et al. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.832345 · Cited by 91
Self-citationGuiraud, D., Andreu, D., Bonnet, S., Carrault, G., Couderc, P., Hagège, A. A., Henry, C., Hernandez, A. I., Karam, N., Rolle, V. L., et al. (2016) · Journal of Neural Engineering · doi:10.1088/1741-2560/13/4/041002 · Cited by 97
“…(CONSENSUS investigators, 1987, AVID investigators, 1997, Kadish et al., 2004) or a cardiac resynchronization device (Cazeau et al., 2001, Bristow et al., 2004, Moss et al., 2009, Linde et al., 2010, Tang et al., 2010, Bogale et al., 2012, McMurray et al., 2012, Brignole et al., 2013).”
BackgroundAdvances and Future Directions in Cardiac Pacemakers
Madhavan, M., Mulpuru, S. K., McLeod, C. J., Cha, Y., & Friedman, P. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.064 · Cited by 92
“All of the randomized controlled trials (RCTs) that have shown improvement in HF symptoms and survival using patients enrolled in CRT with a minimal QRS duration of 120 to 150 ms (3,4,7).”
MethodFernández‐Armenta, J., Berruezo, A., Mont, L., Sitges, M., Andreu, D., Silva, E., Ortiz-Pérez, J. T., Tolosana, J. M., de Caralt, T. M., Perea, R. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus104 · Cited by 87
“A cardiac resynchronization therapy pacemaker (CRT-P), alone or combined with defibrillation capabilities (CRT-D), will induce left ventricular (LV) reverse remodelling, and improve symptoms and survival in patients with heart failure (HF), LV dysfunction, and prolonged QRS duration.(1,2) Both therapies are a class I…”
BackgroundSudden Cardiac Death: Epidemiology, Mechanisms, and Therapy
Turakhia, M. P., & Tseng, Z. H. (2007) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2007.05.002 · Cited by 100
Cost-effectiveness of heart failure therapies
Rohde, L. E. P., Bertoldi, E. G., Goldraich, L. A., & Polanczyk, C. A. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.60 · Cited by 97
Long‐Term Variations in Optimal Programming of Cardiac Resynchronization Therapy Devices
O’Donnell, D., Nadurata, V., HAMER, A. W. F., Kertes, P. J., & MOHAMMED, U. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00070.x · Cited by 86
Fröhlich, G., Steffel, J., Hürlimann, D., Enseleit, F., Lüscher, T. F., Ruschitzka, F. T., Abraham, W. T., & Holzmeister, J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq065 · Cited by 96
Gulizia, M. M., Piraino, L., Scherillo, M., Puntrello, C., Vasco, C., Scianaro, M. C., Mascia, F., Pensabene, O., Giglia, S., Chiarandà, G., et al. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.804211 · Cited by 92
Long-Term Reverse Remodeling With Cardiac Resynchronization Therapy
Verhaert, D., Grimm, R. A., Puntawangkoon, C., Wolski, K., De, S. K., Wilkoff, B. L., Starling, R. C., Tang, W. H. W., Thomas, J. D., & Popović, Z. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.022 · Cited by 88
“Despite the survival enefit of CRT for patients with advanced heart failure, the umulative mortality is still high in this group of patients, anging from 15% to 18% at 1 to 2 years in randomized, ontrolled trials to 34% or higher at 5-year follow-up, as ound by some observational studies (3,5,20).”
BackgroundMandawat, A., Chattranukulchai, P., Mandawat, A., Blood, A. J., Ambati, S., Hayes, B. D., Rehwald, W. G., Kim, H. W., Heitner, J. F., Shah, D. J., et al. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.11.006 · Cited by 92
Sade, L. E., Demir, Ö., Atar, İ., Müderrisoğlu, H., & Özin, B. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.069 · Cited by 86
McLeod, C. J., Shen, W.-K., Rea, R. F., Friedman, P. A., Hayes, D. L., Wokhlu, A., Webster, T. L., Wiste, H. J., Hodge, D. O., Bradley, D. J., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.11.013 · Cited by 86
Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3β
Kirk, J. A., Holewinski, R. J., Kooij, V., Agnetti, G., Tunin, R. S., Witayavanitkul, N., de Tombe, P. P., Gao, W. D., Eyk, J. E. V., & Kass, D. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69253 · Cited by 85
“While dyssynchrony is an independent risk factor in patients with HF, successful CRT reduces mortality (6, 7), perhaps to levels even below those of HF patients without dyssynchrony (8, 9).”
Self-citationTheuns, D. A. M. J., Schaer, B. A., Soliman, O. I. I., Altmann, D., Sticherling, C., Geleijnse, M. L., Osswald, S., & Jordaens, L. J. L. M. (2010) · EP Europace · doi:10.1093/europace/euq328 · Cited by 86
“4 In addition, the efficacy and survival benefits of CRT have been proved in observational studies as well as in randomized trials.(5,6,21) Taken this together, the addition of defibrillation to CRT is reasonable, as the CRT-D targets both HF and arrhythmic mortality.”
BackgroundCongestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) Trial Design
Bartúnek, J., Davison, B. A., Sherman, W., Povsic, T. J., Henry, T. D., Gersh, B. J., Metra, M., Filippatos, G. S., Hajjar, R. J., Behfar, A., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.434 · Cited by 88
Cabac‐Pogorevici, I., Muk, B., Rustamova, Y., Kalogeropoulos, A. S., Tzeis, S. E., & Vardas, P. E. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1747 · Cited by 102
Bibliometric analysis on the Progress of chronic heart failure
Wang, H., Shi, J., Shi, S., Bo, R., Zhang, X., & Hu, Y. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101213 · Cited by 84
Linde, C. M., Gold, M. R., Abraham, W. T., & Daubert, J. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.002 · Cited by 92
Marco, T. D., Wolfel, E. E., Feldman, A. M., Lowes, B. D., Higginbotham, M. B., Ghali, J. K., Wagoner, L. E., Kirlin, P. C., Kennett, J. D., Goel, S., et al. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.08.003 · Cited by 87
Self-citationPazhenkottil, A. P., Buechel, R. R., Husmann, L., Nkoulou, R. N., Wolfrum, M., Ghadri, J. R., Kummer, J., Herzog, B. A., & Kaufmann, P. A. (2010) · Heart · doi:10.1136/hrt.2010.201566 · Cited by 84
Mehta, P. A., Dubrey, S. W., McIntyre, H. F., Walker, D. M., Hardman, S. M. C., Sutton, G. C., McDonagh, T., & Cowie, M. (2009) · Heart · doi:10.1136/hrt.2008.156034 · Cited by 83
Automatic home monitoring of implantable cardioverter defibrillators
Nielsen, J. C., Kottkamp, H., Zabel, M., Aliot, E., Kreutzer, U., Bauer, A., Schuchert, A., Neuser, H., Schumacher, B., Schmidinger, H., et al. (2008) · EP Europace · doi:10.1093/europace/eun099 · Cited by 84
Forleo, G. B., Santini, L., Giammaria, M., Potenza, D. R., Curnis, A., Calabrese, V., Ricciardi, D., D’Agostino, C., Notarstefano, P., Ribatti, V., et al. (2016) · EP Europace · doi:10.1093/europace/euw094 · Cited by 83
“Over the last decade, cardiac resynchronization therapy (CRT) has evolved considerably, becoming established as a treatment option in selected patients with heart failure (HF).(1) – 4 However, the clinical response to CRT remains highly variable and a significant proportion of patients fail to respond positively ( 30%…”
BackgroundLeyva, F., Zegard, A., Acquaye, E., Gubran, C., Taylor, R. J., Foley, P. W. X., Umar, F., Patel, K., Panting, J. R., Marshall, H. J., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.712 · Cited by 83
Wang, L., LAHTINEN, S. P., Lentz, L. R., Rakow, N., Kaszas, C. J., Ruetz, L. L., Stylos, L., & Olson, W. H. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.40009.x · Cited by 83
Rinaldi, C. A., Leclercq, C., Kranig, W., Kacet, S., Betts, T. R., Bordachar, P., Gutleben, K. J., Shetty, A., Donal, E., Keel, A. J., et al. (2014) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-014-9891-1 · Cited by 82
Beela, A. S., Ünlü, S., Duchenne, J., Ciarka, A., Daraban, A. M., Kotrč, M., Aarones, M., Szulik, M., Winter, S., Pěnička, M., et al. (2018) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jey029 · Cited by 88
Reverse remodelling in heart failure with cardiac resynchronisation therapy
Sutton, M. S.-J., & Keane, M. G. (2006) · Heart · doi:10.1136/hrt.2005.067967 · Cited by 82
Varma, N. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.379 · Cited by 94
Outcomes With an Alternate List Strategy for Heart Transplantation
Felker, G. M., Milano, C. A., Yager, J. E. E., Hernandez, A. F., Blue, L. J., Higginbotham, M. B., Lodge, A. J., & Russell, S. D. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2005.03.014 · Cited by 82
Bogaard, M. D., Houthuizen, P., Bracke, F. A. L. E., Doevendans, P. A., Prinzen, F. W., Meine, M., & van Gelder, B. M. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr094 · Cited by 85
State of the art of leadless pacing
Sperzel, J., Burri, H., Gras, D., Tjong, F. V. Y., Knops, R. E., Hindricks, G., Steinwender, C., & Defaye, P. (2015) · Europace · doi:10.1093/europace/euv096 · Cited by 81
he, S. T., Wu, J., Li, S.-H., Wang, L., Sun, Y., Xie, J., Ramnath, D., Weisel, R. D., Yau, T. M., Sung, H., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120285 · Cited by 81
Ousdigian, K. T., Borek, P., Koehler, J. L., Heywood, J. T., Ziegler, P., & Wilkoff, B. L. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001212 · Cited by 84
Metadata
- Authors
- Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., DeVries, D. W., & Feldman, A. M.
- Affiliations
- University of Colorado Health (US)
- University of Southern California (US)
- Penn State Milton S. Hershey Medical Center (US)
- Bryan Health (US)
- Johns Hopkins Hospital (US)
- Veterans Health Administration (US)
- Pfizer (United States) (US)
- University of Wisconsin–Madison (US)
- Thomas Jefferson University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-05-20
- Volume
- 350
- Issue
- 21
- Pages
- 2140-2150
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130907431
- Cited by
- 5,812
- References
- 22
- Citations by year
- 2026: 80 · 2025: 126 · 2024: 131 · 2023: 179 · 2022: 149 · 2021: 157 · 2020: 196 · 2019: 213 · 2018: 210 · 2017: 265 · 2016: 260 · 2015: 308 · 2014: 276 · 2013: 323 · 2012: 350
- FWCI
- 240.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
- Keywords
- cardiac resynchronization therapy, implantable cardioverter-defibrillator, advanced chronic heart failure, intraventricular conduction delay, heart failure hospitalization, mortality, cardiomyopathy, QRS duration, pharmacotherapy
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angiotensin-Converting Enzyme Inhibitors, Chronic Disease, Combined Modality Therapy, Diuretics, Female, Heart Failure, Hospitalization, Humans, Male, Pacemaker, Artificial, Risk, Spironolactone, Defibrillators, Implantable, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.